VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer

Incidents per State

State Total
88,334
AK1,815
AL6,133
AR3,993
AS45
AZ14,539
CA64,759
CO12,159
CT8,719
DC1,747
DE1,868
FL41,499
FM3
GA16,132
GU92
HI2,477
IA4,739
ID2,763
IL21,496
IN23,655
KS4,844
KY8,414
LA5,328
MA15,281
MD13,105
ME3,277
MH8
MI20,143
MN12,873
MO10,275
MP30
MS3,073
MT2,392
NC17,450
ND1,440
NE3,023
NH3,124
NJ19,456
NM4,089
NV4,600
NY36,525
OH20,140
OK6,525
OR8,918
PA24,920
PR2,483
QM2
RI2,092
SC6,952
SD1,243
TN10,038
TX38,745
UT4,482
VA15,477
VI62
VT1,780
WA15,487
WI11,573
WV2,461
WY894
XB5
XL1
XV2

ID: 1562496
Sex: F
Age: 67
State: FL

Vax Date: 03/03/2021
Onset Date: 03/04/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fever of 101.4; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever of 101.4) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014120A) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced PYREXIA (Fever of 101.4). At the time of the report, PYREXIA (Fever of 101.4) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Pyrexia: 101.4 degree. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment details included None. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1562497
Sex: M
Age:
State: TX

Vax Date: 01/30/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: fever; headache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever) and HEADACHE (headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007m20a) for COVID-19 vaccination. No Medical History information was reported. On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever) and HEADACHE (headache). At the time of the report, PYREXIA (fever) and HEADACHE (headache) outcome was unknown. No Concomitant medications were provided No Treatment information provided This case was linked to MOD-2021-034308 (Patient Link).

Other Meds:

Current Illness:

ID: 1562498
Sex: M
Age: 90
State:

Vax Date: 03/03/2021
Onset Date: 03/03/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Chills; Tiredness; This spontaneous case was reported by a physician and describes the occurrence of CHILLS (Chills) and FATIGUE (Tiredness) in a 90-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination. The patient's past medical history included No adverse event and Diabetes since an unknown date. Concomitant products included LINAGLIPTIN (TRADJENTA) for an unknown indication. On 03-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced CHILLS (Chills) and FATIGUE (Tiredness). At the time of the report, CHILLS (Chills) and FATIGUE (Tiredness) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Treatment details included Tylenol This case was linked to MOD-2021-016540 (Patient Link). Reporter did not allow further contact

Other Meds: TRADJENTA

Current Illness: Diabetes

ID: 1562499
Sex: M
Age: 84
State:

Vax Date: 02/18/2021
Onset Date: 02/25/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: It's been itching; huge rash in the injection site, in their junk, in the middle of their back; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of PRURITUS (It's been itching) and RASH (huge rash in the injection site, in their junk, in the middle of their back) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination. Concurrent medical conditions included Atrial fibrillation, Hypothyroidism and Diabetes. On 18-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced PRURITUS (It's been itching) and RASH (huge rash in the injection site, in their junk, in the middle of their back). At the time of the report, PRURITUS (It's been itching) and RASH (huge rash in the injection site, in their junk, in the middle of their back) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Treatment details included Cortisone cream.

Other Meds:

Current Illness: Atrial fibrillation; Diabetes; Hypothyroidism

ID: 1562500
Sex: U
Age:
State: TX

Vax Date:
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: nauseated; Redness; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nauseated) and ERYTHEMA (Redness) in a 30-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced NAUSEA (nauseated) and ERYTHEMA (Redness). At the time of the report, NAUSEA (nauseated) and ERYTHEMA (Redness) outcome was unknown. Concomitant medication was not provided by the reporter. The treatment medication was unknown. This case was linked to MOD-2021-034270 (Patient Link).

Other Meds:

Current Illness:

ID: 1562501
Sex: F
Age:
State: WI

Vax Date: 03/03/2021
Onset Date: 03/03/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Sligth temperature; Achy; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Sligth temperature) and PAIN (Achy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced PYREXIA (Sligth temperature) and PAIN (Achy). At the time of the report, PYREXIA (Sligth temperature) and PAIN (Achy) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1562502
Sex: M
Age: 69
State: KY

Vax Date: 02/25/2021
Onset Date: 02/28/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue), PYREXIA (fever), CHILLS (chills), HYPERHIDROSIS (sweating) and TREMOR (uncontrollable shaking) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022M20A and 0081321-2A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concomitant products included MULTIVITAMIN & MINERAL, AMLODIPINE and DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE, METFORMIN HYDROCHLORIDE (XIGDUO XR). On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Feb-2021, the patient experienced FATIGUE (fatigue) and PYREXIA (fever). On 03-Mar-2021, the patient experienced CHILLS (chills), HYPERHIDROSIS (sweating) and TREMOR (uncontrollable shaking). On an unknown date, the patient experienced CYSTITIS (Bladder infection). At the time of the report, FATIGUE (fatigue), PYREXIA (fever), CHILLS (chills), HYPERHIDROSIS (sweating), TREMOR (uncontrollable shaking) and CYSTITIS (Bladder infection) outcome was unknown. mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) dosing remained unchanged. Treatment medication included Alot of water and two tylenol. Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: New event: Bladder infection added,2nd dose information added.

Other Meds: MULTIVITAMIN & MINERAL; AMLODIPINE; XIGDUO XR

Current Illness:

ID: 1562503
Sex: F
Age:
State: OH

Vax Date: 02/28/2021
Onset Date: 02/28/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: tenderness to left arm; A spontaneous report was received from a consumer concerning a female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events tenderness to left arm/vaccination site pain. The patient's medical history was not provided. Concomitant medications reported were Hydrochlorothiazide, Atorvastatin, Bisoprolol Fumarate, Baby Aspirin for drug use for unknown indication. On 28 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: O25A214) via unknown route for prophylaxis of COVID-19 infection. On 28 Feb 2021, the patient experienced the event, tenderness to left arm. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not reported. On 1 Mar 2021 the outcome of event, tenderness to left arm was resolved.

Other Meds: HYDROCHLOROTHIAZIDE; ATORVASTATIN; BISOPROLOL FUMARATE; BABY ASPIRIN

Current Illness:

ID: 1562504
Sex: F
Age: 64
State:

Vax Date: 02/05/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Second shot rescheduled for March 13th, and there will be a difference of more than 36 days; This spontaneous case was reported by a consumer and describes the occurrence of OFF LABEL USE (Second shot rescheduled for March 13th, and there will be a difference of more than 36 days) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced OFF LABEL USE (Second shot rescheduled for March 13th, and there will be a difference of more than 36 days). At the time of the report, OFF LABEL USE (Second shot rescheduled for March 13th, and there will be a difference of more than 36 days) outcome was unknown. No treatment information was reported. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1562505
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: muscle pain; low-grade fever; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (muscle pain) and PYREXIA (low-grade fever) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The patient's past medical history included No adverse event (no historical condition were reported.). No concomitant medication reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MYALGIA (muscle pain) and PYREXIA (low-grade fever). At the time of the report, MYALGIA (muscle pain) and PYREXIA (low-grade fever) outcome was unknown. No treatment medication was reported. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1562506
Sex: F
Age:
State:

Vax Date: 02/25/2021
Onset Date: 02/25/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: arm is very sore and sensitive off and on; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm is very sore and sensitive off and on) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 25-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 25-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm is very sore and sensitive off and on). At the time of the report, PAIN IN EXTREMITY (arm is very sore and sensitive off and on) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant drugs were taken. No treatment drugs were taken. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1562507
Sex: F
Age:
State:

Vax Date: 02/25/2021
Onset Date: 02/01/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: sharp pain in calf; sharp breast pain; stomach was on fire; heart beating in her ears; headache; lost her balance; lips went numb all the way up to the corner of her eye; something seems off and wrong, fuzzy, foggy, almost like she is going up a mountain and her ears will not pop; confused; waking up in the middle of the night with severe leg cramps; dehydrated; This spontaneous case was reported by a consumer and describes the occurrence of BALANCE DISORDER (lost her balance), HYPOAESTHESIA ORAL (lips went numb all the way up to the corner of her eye), FEELING ABNORMAL (something seems off and wrong, fuzzy, foggy, almost like she is going up a mountain and her ears will not pop), CONFUSIONAL STATE (confused) and MUSCLE SPASMS (waking up in the middle of the night with severe leg cramps) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A023m20a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Family history included Factor V deficiency (Not clear what type but mentioned "brother and other family member" as well) since an unknown date. Concurrent medical conditions included DVT (Another blood clot 2020, right leg. Found out she had "Factor 5") since 2020, Vestibular migraine (On-going, takes topiramate and uses fiorcet for breakthrough migraine), Penicillin allergy, Drug hypersensitivity and Drug hypersensitivity ("Red, skin peeled"). Concomitant products included RIVAROXABAN (XARELTO) for DVT, BUTALBITAL, CAFFEINE, PARACETAMOL (FIORICET) for Migraine, TOPIRAMATE for Vestibular migraine, RIVAROXABAN (XARELTO), TOPIRAMATE and Fiorcet for an unknown indication. On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, the patient experienced FEELING ABNORMAL (something seems off and wrong, fuzzy, foggy, almost like she is going up a mountain and her ears will not pop), CONFUSIONAL STATE (confused), MUSCLE SPASMS (waking up in the middle of the night with severe leg cramps), DEHYDRATION (dehydrated), FEELING ABNORMAL (foggy), the first episode of FEELING ABNORMAL (foggy comes and goes almost like she is going up a mountain and her ears will not pop) and the second episode of FEELING ABNORMAL (foggy comes and goes almost like she is going up a mountain and her ears will not pop). On 25-Feb-2021, the patient experienced BALANCE DISORDER (lost her balance), HYPOAESTHESIA ORAL (lips went numb all the way up to the corner of her eye) and HEADACHE (headache). On 28-Feb-2021, the patient experienced BREAST PAIN (sharp breast pain), DYSPEPSIA (stomach was on fire) and PALPITATIONS (heart beating in her ears). On 01-Mar-2021, the patient experienced PAIN IN EXTREMITY (sharp pain in calf). At the time of the report, FEELING ABNORMAL (something seems off and wrong, fuzzy, foggy, almost like she is going up a mountain and her ears will not pop) and the last episode of FEELING ABNORMAL (foggy comes and goes almost like she is going up a mountain and her ears will not pop) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. The patient's medical history of blood clots and vestibular migraines remains the contributing factors.

Other Meds: XARELTO; TOPIRAMATE; FIORICET

Current Illness: Drug hypersensitivity (sulfa); DVT (Another blood clot 2020, right leg. Found out she had "Factor 5"); Factor V deficiency (Not clear what type but mentioned "brother and other family member" as well); Penicillin allergy; Vestibular migraine (On-going, takes topiramate and uses fiorcet for breakthrough migraine)

ID: 1562508
Sex: M
Age: 90
State: CA

Vax Date: 02/03/2021
Onset Date: 03/02/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: chills; fever (his temperature was 104-105?F); muscle weakness in legs and shoulders; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), PYREXIA (fever (his temperature was 104-105?F)) and MUSCULAR WEAKNESS (muscle weakness in legs and shoulders) in a 90-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004M20A and 022M20A) for COVID-19 vaccination. Concurrent medical conditions included Blood pressure high and Thyroid disorder NOS. On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Mar-2021, the patient experienced CHILLS (chills), PYREXIA (fever (his temperature was 104-105?F)) and MUSCULAR WEAKNESS (muscle weakness in legs and shoulders). On 03-Feb-2021, CHILLS (chills) had resolved. At the time of the report, PYREXIA (fever (his temperature was 104-105?F)) and MUSCULAR WEAKNESS (muscle weakness in legs and shoulders) had not resolved. Treatment information was not provided. This case was linked to MOD-2021-033733 (Patient Link).

Other Meds:

Current Illness: Blood pressure high; Thyroid disorder NOS

ID: 1562509
Sex: F
Age: 62
State: GA

Vax Date: 03/03/2021
Onset Date: 03/04/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Itching; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination. No Medical History information was reported. On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced PRURITUS (Itching). At the time of the report, PRURITUS (Itching) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication reported. No treatment information reported. Most recent FOLLOW-UP information incorporated above includes: On 16-Jun-2021: Event outcome was updated to recovered.

Other Meds:

Current Illness:

ID: 1562510
Sex: F
Age: 34
State: TX

Vax Date: 02/20/2021
Onset Date: 02/01/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Vaccine exposure during pregnancy; Rash that was red on opposite arm from the arm she had received the vaccination; Rash inflamed and on the opposite arm from the arm she had received the vaccination; This spontaneous prospective pregnancy case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy), RASH ERYTHEMATOUS (Rash that was red on opposite arm from the arm she had received the vaccination) and INFLAMMATION (Rash inflamed and on the opposite arm from the arm she had received the vaccination) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007M20A and 037A21B) for COVID-19 vaccination. Concurrent medical conditions included Allergy to antibiotic (Allergies to Ceclor, Amoxil, Bactrim). Concomitant products included DOXYLAMINE SUCCINATE, PYRIDOXINE HYDROCHLORIDE (BONJESTA) from 23-Nov-2020 to an unknown date for Nausea, PRENATAL MULTIVITAMIN + DHA for Pregnancy. On 20-Feb-2021 at 3:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on 04-Oct-2020 and the estimated date of delivery was 11-Jul-2021. In February 2021, the patient experienced RASH ERYTHEMATOUS (Rash that was red on opposite arm from the arm she had received the vaccination) and INFLAMMATION (Rash inflamed and on the opposite arm from the arm she had received the vaccination). On 20-Feb-2021, the patient experienced EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the twentieth week of the pregnancy. The delivery occurred on an unknown date, which was reported as Unknown. For neonate 1, The outcome was reported as Unknown. On 20-Feb-2021, EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved. At the time of the report, RASH ERYTHEMATOUS (Rash that was red on opposite arm from the arm she had received the vaccination) and INFLAMMATION (Rash inflamed and on the opposite arm from the arm she had received the vaccination) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Nov-2020, Ultrasound abdomen: normal (normal) normal. On 14-Dec-2020, Prenatal screening test: normal (normal) normal. On 02-Feb-2021, Ultrasound abdomen: normal (normal) normal. On 25-Feb-2021, Alpha 1 foetoprotein normal: normal (normal) normal. Treatment information for rash was not provided Most recent FOLLOW-UP information incorporated above includes: On 29-Mar-2021: Second vaccination information. Reporting of an AE not previously reported after first injection.

Other Meds: BONJESTA; PRENATAL MULTIVITAMIN + DHA

Current Illness: Allergy to antibiotic (Allergies to Ceclor, Amoxil, Bactrim)

ID: 1562511
Sex: M
Age:
State: AR

Vax Date: 03/03/2021
Onset Date: 03/04/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: arm is sore at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (arm is sore at the injection site) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced VACCINATION SITE PAIN (arm is sore at the injection site). At the time of the report, VACCINATION SITE PAIN (arm is sore at the injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1562512
Sex: F
Age:
State: NJ

Vax Date: 02/24/2021
Onset Date: 02/25/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in the arm), VACCINATION SITE ERYTHEMA (Rednnes and itch in the injection site area) and VACCINATION SITE PRURITUS (Rednnes and itch in the injection site area) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. The patient's past medical history included No adverse event (No medical history reported). On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced PAIN IN EXTREMITY (pain in the arm). In March 2021, the patient experienced VACCINATION SITE ERYTHEMA (Rednnes and itch in the injection site area) and VACCINATION SITE PRURITUS (Rednnes and itch in the injection site area). On 26-Feb-2021, PAIN IN EXTREMITY (pain in the arm) had resolved. At the time of the report, VACCINATION SITE ERYTHEMA (Rednnes and itch in the injection site area) and VACCINATION SITE PRURITUS (Rednnes and itch in the injection site area) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Treatment information was not provided.

Other Meds:

Current Illness:

ID: 1562513
Sex: M
Age: 67
State: VA

Vax Date: 03/01/2021
Onset Date: 03/01/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: body aches; joint pain on left toe after 2nd dose; Joint pain on left toe; diarrhea; flu like symptoms; pain on injection site; fatigue; Difficult to walk; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (Difficult to walk), DIARRHOEA (diarrhea), INFLUENZA LIKE ILLNESS (flu like symptoms), ARTHRALGIA (joint pain on left toe after 2nd dose) and ARTHRALGIA (Joint pain on left toe) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002A21A and 048A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Squamous cell carcinoma of the tongue on 01-Jun-2004. Concurrent medical conditions included Iodine allergy (Iodine), Hypertension since 01-Feb-2007 and Gout. Concomitant products included TELMISARTAN for an unknown indication. On 01-Mar-2021 at 1:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021 at 3:00 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms), VACCINATION SITE PAIN (pain on injection site) and FATIGUE (fatigue). On 03-Mar-2021, the patient experienced DIARRHOEA (diarrhea). On 13-Mar-2021, the patient experienced ARTHRALGIA (Joint pain on left toe). On 12-Apr-2021, the patient experienced ARTHRALGIA (joint pain on left toe after 2nd dose). On an unknown date, the patient experienced GAIT DISTURBANCE (Difficult to walk) and MYALGIA (body aches). The patient was treated with BIFIDOBACTERIUM INFANTIS (ALIGN) for Diarrhea, at an unspecified dose and frequency. On 06-Mar-2021, DIARRHOEA (diarrhea) had resolved. On 23-Mar-2021, ARTHRALGIA (Joint pain on left toe) had resolved. On 30-Apr-2021, ARTHRALGIA (joint pain on left toe after 2nd dose) had resolved. At the time of the report, GAIT DISTURBANCE (Difficult to walk) had resolved and INFLUENZA LIKE ILLNESS (flu like symptoms), VACCINATION SITE PAIN (pain on injection site), FATIGUE (fatigue) and MYALGIA (body aches) outcome was unknown. This case was linked to MOD-2021-243762 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 30-Jun-2021: Significant Follow up received on 30-JUN-2021. Patient details were added., Other relevant history were added. Concomitant medications and vaccine facility information were added. New events were reported.

Other Meds: TELMISARTAN

Current Illness: Gout; Hypertension; Iodine allergy (Iodine)

ID: 1562514
Sex: M
Age: 67
State: FL

Vax Date: 01/04/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: light-headed; anxiety; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (light-headed) and ANXIETY (anxiety) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011L20A and 032L20A) for COVID-19 vaccination. The patient's past medical history included No adverse event (No medical history reported). Concomitant products included METFORMIN, ATORVASTATIN CALCIUM (LIPITOR) and LISINOPRIL for an unknown indication. On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIZZINESS (light-headed) and ANXIETY (anxiety). At the time of the report, DIZZINESS (light-headed) and ANXIETY (anxiety) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. This case was linked to MOD-2021-034353, MOD-2021-034353 (Patient Link).

Other Meds: METFORMIN; LIPITOR; LISINOPRIL

Current Illness:

ID: 1562515
Sex: F
Age: 70
State: CO

Vax Date: 02/10/2021
Onset Date: 02/10/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Bad diarrhea for 2 weeks; felt like throat wanted to swell up; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Bad diarrhea for 2 weeks) and PHARYNGEAL SWELLING (felt like throat wanted to swell up) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027l20a) for COVID-19 vaccination. The patient's past medical history included No adverse event (No medical history reported). Concomitant products included METFORMIN for an unknown indication. On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced DIARRHOEA (Bad diarrhea for 2 weeks) and PHARYNGEAL SWELLING (felt like throat wanted to swell up). At the time of the report, DIARRHOEA (Bad diarrhea for 2 weeks) had resolved and PHARYNGEAL SWELLING (felt like throat wanted to swell up) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment information was not provided.

Other Meds: METFORMIN

Current Illness:

ID: 1562516
Sex: M
Age: 67
State: OH

Vax Date: 03/03/2021
Onset Date: 03/04/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: could not sleep; felt jittery; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (could not sleep) and FEELING JITTERY (felt jittery) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. No Medical History information was reported. On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced INSOMNIA (could not sleep) and FEELING JITTERY (felt jittery). At the time of the report, INSOMNIA (could not sleep) outcome was unknown and FEELING JITTERY (felt jittery) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medication was reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1562517
Sex: M
Age:
State: TX

Vax Date: 01/22/2021
Onset Date: 01/30/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Has not received the second shot 36 days post first vaccine, can not find appointments; A Spontaneous report was received from a consumer concerning a 21 years old, male patient who experienced had not received the second shot 36 days post first vaccine, can not find appointments. The patient's medical history was included was kidney disease. No Concomitant medications were reported. On 22 Jan 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Batch number: [LOT/BATCH: unknown] intramuscular route for prophylaxis of COVID-19 infection. On 30 Jan 2021, the patient experienced not received the second shot 36 days post first vaccine, can not find appointments. Action taken with mRNA-1273 in response to the events was not provided. The outcome of the event, had not received the second shot 36 days post first vaccine, can not find appointments was considered as recovered on 30 Jan 2021.; Reporter's Comments: This report also refers to a case of Inappropriate schedule of product administration for mRNA-1273 (lot # unknown), with no associated AEs. Further information has been requested.

Other Meds:

Current Illness:

ID: 1562518
Sex: M
Age: 67
State: FL

Vax Date: 01/04/2021
Onset Date: 02/04/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: some bumps in forehead; fever; chills; knee pain; very bad headache; This spontaneous case was reported by a patient family member or friend and describes the occurrence of MASS (some bumps in forehead), PYREXIA (fever), CHILLS (chills), ARTHRALGIA (knee pain) and HEADACHE (very bad headache) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L20A and 011L20A) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included METFORMIN, ATORVASTATIN CALCIUM (LIPITOR) and LISINOPRIL for an unknown indication. On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Feb-2021, the patient experienced MASS (some bumps in forehead), PYREXIA (fever), CHILLS (chills), ARTHRALGIA (knee pain) and HEADACHE (very bad headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, MASS (some bumps in forehead), PYREXIA (fever), CHILLS (chills), ARTHRALGIA (knee pain) and HEADACHE (very bad headache) outcome was unknown. This case was linked to MOD-2021-034348 (Patient Link).

Other Meds: METFORMIN; LIPITOR; LISINOPRIL

Current Illness:

ID: 1562519
Sex: F
Age:
State: NY

Vax Date: 02/12/2021
Onset Date: 02/12/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: felt nauseous for only 15 seconds; she felt warm; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (she felt warm) and NAUSEA (felt nauseous for only 15 seconds) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination. No Medical History information was reported. On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced FEELING HOT (she felt warm). On 13-Feb-2021, the patient experienced NAUSEA (felt nauseous for only 15 seconds). At the time of the report, FEELING HOT (she felt warm) and NAUSEA (felt nauseous for only 15 seconds) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant drugs were reported. No treatment drugs were reported.

Other Meds:

Current Illness:

ID: 1562520
Sex: F
Age: 84
State: NY

Vax Date: 01/27/2021
Onset Date: 02/07/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea/loose/soft bowel movements) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 002A21A) for COVID-19 vaccination. The patient's past medical history included Colectomy since an unknown date. On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Feb-2021, the patient experienced DIARRHOEA (diarrhea/loose/soft bowel movements). At the time of the report, DIARRHOEA (diarrhea/loose/soft bowel movements) had not resolved. Treatment for the events includes pedialyte, bismuth subsalicylate

Other Meds:

Current Illness: Colectomy

ID: 1562521
Sex: M
Age: 29
State: IL

Vax Date: 02/09/2021
Onset Date: 02/01/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: tested positive for COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (tested positive for COVID-19) in a 29-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced COVID-19 (tested positive for COVID-19). On 24-Feb-2021, COVID-19 (tested positive for COVID-19) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, COVID-19: positive (Positive) Positive. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication and treatment medication were not reported.

Other Meds:

Current Illness:

ID: 1562522
Sex: F
Age: 91
State: FL

Vax Date: 02/02/2021
Onset Date: 02/02/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Soreness at injection site; This spontaneous case was reported by a health care professional and describes the occurrence of VACCINATION SITE PAIN (Soreness at injection site) in a 91-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031M20A and 031M20A) for COVID-19 vaccination. The patient's past medical history included No adverse event (No medical history reported). On 02-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Feb-2021, the patient experienced VACCINATION SITE PAIN (Soreness at injection site). At the time of the report, VACCINATION SITE PAIN (Soreness at injection site) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Treatment information not provided.

Other Meds:

Current Illness:

ID: 1562523
Sex: M
Age: 74
State: PA

Vax Date: 03/02/2021
Onset Date: 03/02/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fever; Pain in hip; Back pain; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), ARTHRALGIA (Pain in hip) and BACK PAIN (Back pain) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination. The patient's past medical history included No adverse event (No medial history reported). On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced PYREXIA (Fever), ARTHRALGIA (Pain in hip) and BACK PAIN (Back pain). At the time of the report, PYREXIA (Fever), ARTHRALGIA (Pain in hip) and BACK PAIN (Back pain) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment included aspirin. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1562524
Sex: F
Age:
State: OH

Vax Date: 03/03/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Some side effects (didn't mention which); This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Some side effects (didn't mention which)) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Some side effects (didn't mention which)). At the time of the report, VACCINATION COMPLICATION (Some side effects (didn't mention which)) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1562525
Sex: F
Age:
State: MO

Vax Date: 01/12/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: lymph nodes under the arm, neck, chin, at the back of the head; sore arm; could hardly lift her head up; had a knot under; stomach hurt really bad; worst migraine; have 40 fever blisters on her lips; fever at the injection site; body aches; fever; severe chills for over 24 hours; joint pain; red around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (lymph nodes under the arm, neck, chin, at the back of the head), PAIN IN EXTREMITY (sore arm), HEAD DISCOMFORT (could hardly lift her head up), RASH MACULAR (had a knot under) and ABDOMINAL DISCOMFORT (stomach hurt really bad) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included No adverse event (No medical history reported). Concomitant products included LEVOTHYROXINE, PROPRANOLOL and VITAMINS NOS for an unknown indication. On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (lymph nodes under the arm, neck, chin, at the back of the head), PAIN IN EXTREMITY (sore arm), HEAD DISCOMFORT (could hardly lift her head up), RASH MACULAR (had a knot under), ABDOMINAL DISCOMFORT (stomach hurt really bad), MIGRAINE (worst migraine), ORAL HERPES (have 40 fever blisters on her lips), VACCINATION SITE REACTION (fever at the injection site), MYALGIA (body aches), PYREXIA (fever), CHILLS (severe chills for over 24 hours), ARTHRALGIA (joint pain) and VACCINATION SITE ERYTHEMA (red around the injection site). At the time of the report, LYMPHADENOPATHY (lymph nodes under the arm, neck, chin, at the back of the head), PAIN IN EXTREMITY (sore arm), HEAD DISCOMFORT (could hardly lift her head up), RASH MACULAR (had a knot under), ABDOMINAL DISCOMFORT (stomach hurt really bad), MIGRAINE (worst migraine), ORAL HERPES (have 40 fever blisters on her lips), VACCINATION SITE REACTION (fever at the injection site), MYALGIA (body aches), PYREXIA (fever), CHILLS (severe chills for over 24 hours), ARTHRALGIA (joint pain) and VACCINATION SITE ERYTHEMA (red around the injection site) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Treatment included paracetamol and ibuprofen, ice bags on head

Other Meds: LEVOTHYROXINE; PROPRANOLOL; VITAMINS NOS

Current Illness:

ID: 1562526
Sex: F
Age:
State: NY

Vax Date: 03/01/2021
Onset Date: 03/03/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Runny Nose; Sneezing; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (Runny Nose) and SNEEZING (Sneezing) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event (No medical history reported). On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced RHINORRHOEA (Runny Nose) and SNEEZING (Sneezing). At the time of the report, RHINORRHOEA (Runny Nose) and SNEEZING (Sneezing) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Treatment information was not provided.

Other Meds:

Current Illness:

ID: 1562527
Sex: F
Age: 82
State: DE

Vax Date: 03/01/2021
Onset Date: 03/01/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Slightly swollen at injection site; Red at injection site; Slightly swollen from middle of fore arm down the arm; Red from middle of forearm down the arm.; arm a little warm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Slightly swollen at injection site), VACCINATION SITE ERYTHEMA (Red at injection site), PERIPHERAL SWELLING (Slightly swollen from middle of fore arm down the arm), ERYTHEMA (Red from middle of forearm down the arm.) and VACCINATION SITE WARMTH (arm a little warm) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025a21a) for COVID-19 vaccination. The patient's past medical history included No adverse event (No medical history reported). On 01-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced VACCINATION SITE SWELLING (Slightly swollen at injection site), VACCINATION SITE ERYTHEMA (Red at injection site), PERIPHERAL SWELLING (Slightly swollen from middle of fore arm down the arm), ERYTHEMA (Red from middle of forearm down the arm.) and VACCINATION SITE WARMTH (arm a little warm). At the time of the report, VACCINATION SITE SWELLING (Slightly swollen at injection site), VACCINATION SITE ERYTHEMA (Red at injection site), PERIPHERAL SWELLING (Slightly swollen from middle of fore arm down the arm), ERYTHEMA (Red from middle of forearm down the arm.) and VACCINATION SITE WARMTH (arm a little warm) outcome was unknown. Treatment information was not provided.

Other Meds:

Current Illness:

ID: 1562528
Sex: M
Age: 57
State: VA

Vax Date: 01/20/2021
Onset Date: 01/20/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: dry cough; irritation rather than a real cough; little bit queasy; fatigued; muscle pain; felt like someone punched me in the arm twice; minor sore arm; felt like someone punched me in the arm; This spontaneous case was reported by an other (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (minor sore arm), FEELING ABNORMAL (felt like someone punched me in the arm), MYALGIA (muscle pain), FEELING ABNORMAL (felt like someone punched me in the arm twice) and NAUSEA (little bit queasy) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L20A and 024M20A) for Covid-19 Vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Asthma. Concomitant products included ATORVASTATIN for product use for unkown indication. On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 20-Jan-2021, the patient experienced PAIN IN EXTREMITY (minor sore arm) and FEELING ABNORMAL (felt like someone punched me in the arm). On 24-Feb-2021, the patient experienced MYALGIA (muscle pain) and FEELING ABNORMAL (felt like someone punched me in the arm twice). On 25-Feb-2021, the patient experienced NAUSEA (little bit queasy) and FATIGUE (fatigued). On 26-Feb-2021, the patient experienced COUGH (dry cough) and THROAT IRRITATION (irritation rather than a real cough). On 22-Jan-2021, FEELING ABNORMAL (felt like someone punched me in the arm) had resolved. On 26-Feb-2021, NAUSEA (little bit queasy) and FATIGUE (fatigued) had resolved. On 27-Feb-2021, MYALGIA (muscle pain) and FEELING ABNORMAL (felt like someone punched me in the arm twice) had resolved. At the time of the report, COUGH (dry cough) and THROAT IRRITATION (irritation rather than a real cough) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No treatment information was provided. This case was linked to MOD-2021-034387, MOD-2021-034387 (Patient Link).

Other Meds: ATORVASTATIN

Current Illness:

ID: 1562529
Sex: U
Age:
State: NV

Vax Date: 02/26/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Lethargy; Sniffles; This spontaneous case was reported by a consumer and describes the occurrence of LETHARGY (Lethargy) and RHINORRHOEA (Sniffles) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LETHARGY (Lethargy) and RHINORRHOEA (Sniffles). At the time of the report, LETHARGY (Lethargy) and RHINORRHOEA (Sniffles) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.

Other Meds:

Current Illness:

ID: 1562530
Sex: F
Age: 61
State: IA

Vax Date: 02/24/2021
Onset Date: 02/24/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: felt like she was injected with poison; never had this much pain before/pain in the strangest places; eye sockets feel like they are going to fall out; hard to hold her head up; armpit sore at injection site; cannot sleep; cannot rest; skin between her toes are horrendous; nerves are on fire; feels like a porcupine pricked her; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (felt like she was injected with poison), PAIN (never had this much pain before/pain in the strangest places), OCULAR DISCOMFORT (eye sockets feel like they are going to fall out), HEAD DISCOMFORT (hard to hold her head up) and VACCINATION SITE PAIN (armpit sore at injection site) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Fibromyalgia and Cancer. Concomitant products included ZOLPIDEM, AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL), AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL), LEVOTHYROXINE, DULOXETINE HYDROCHLORIDE (CYMBALTA) and DULOXETINE HYDROCHLORIDE (CYMBALTA) for an unknown indication. On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced FEELING ABNORMAL (felt like she was injected with poison), PAIN (never had this much pain before/pain in the strangest places), OCULAR DISCOMFORT (eye sockets feel like they are going to fall out), HEAD DISCOMFORT (hard to hold her head up), VACCINATION SITE PAIN (armpit sore at injection site), INSOMNIA (cannot sleep), RESTLESSNESS (cannot rest), SKIN DISCOMFORT (skin between her toes are horrendous), NEURALGIA (nerves are on fire) and PAIN (feels like a porcupine pricked her). At the time of the report, FEELING ABNORMAL (felt like she was injected with poison), PAIN (never had this much pain before/pain in the strangest places), OCULAR DISCOMFORT (eye sockets feel like they are going to fall out), HEAD DISCOMFORT (hard to hold her head up), VACCINATION SITE PAIN (armpit sore at injection site), INSOMNIA (cannot sleep), RESTLESSNESS (cannot rest), SKIN DISCOMFORT (skin between her toes are horrendous), NEURALGIA (nerves are on fire) and PAIN (feels like a porcupine pricked her) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment for the events include ibuprofen, ice, heating pad.

Other Meds: ZOLPIDEM; ADDERALL; ADDERALL; LEVOTHYROXINE; CYMBALTA; CYMBALTA

Current Illness: Cancer; Fibromyalgia

ID: 1562531
Sex: F
Age: 39
State: IL

Vax Date: 02/01/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Coughing; coughing up mucus; fatigue; shortness of breath; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Coughing), COUGH (coughing up mucus), FATIGUE (fatigue) and DYSPNOEA (shortness of breath) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038K20A and 006M20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COUGH (Coughing), COUGH (coughing up mucus), FATIGUE (fatigue) and DYSPNOEA (shortness of breath). At the time of the report, COUGH (Coughing), COUGH (coughing up mucus), FATIGUE (fatigue) and DYSPNOEA (shortness of breath) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant information were not provided by the reporter. Treatment information were not provided by the reporter.

Other Meds:

Current Illness:

ID: 1562532
Sex: F
Age:
State:

Vax Date: 02/24/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Stiff neck; pain in back; shortness of breath; sore arm; pain in right side of entire body/pain; I am still weak/ Minimal energy level; fatigue; chills; headache; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (Stiff neck), BACK PAIN (pain in back), DYSPNOEA (shortness of breath), PAIN IN EXTREMITY (sore arm) and PAIN (pain in right side of entire body/pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MUSCULOSKELETAL STIFFNESS (Stiff neck), BACK PAIN (pain in back), DYSPNOEA (shortness of breath), PAIN IN EXTREMITY (sore arm), PAIN (pain in right side of entire body/pain), ASTHENIA (I am still weak/ Minimal energy level), FATIGUE (fatigue), CHILLS (chills) and HEADACHE (headache). At the time of the report, MUSCULOSKELETAL STIFFNESS (Stiff neck), BACK PAIN (pain in back), PAIN IN EXTREMITY (sore arm), PAIN (pain in right side of entire body/pain), ASTHENIA (I am still weak/ Minimal energy level), FATIGUE (fatigue) and CHILLS (chills) outcome was unknown and DYSPNOEA (shortness of breath) and HEADACHE (headache) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant product use was not provided by the reporter. No treatment information was provided. Most recent FOLLOW-UP information incorporated above includes: On 02-May-2021: Follow up received contains added New Events(Musculoskeletal Stiffness, Back pain, Dyspnoea, pain) and Outcome of the Event Headache changed to Not recovered. On 12-Jul-2021: Follow-up received Contains New event Asthenia added and for events dyspnea and headache outcome updated to not resolved.

Other Meds:

Current Illness:

ID: 1562533
Sex: F
Age: 52
State: TN

Vax Date: 02/22/2021
Onset Date: 03/01/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: sweating bad; feels hot and cold; shakes like she was nervous; hoarse; nauseated; throwing up; headache; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweating bad), FEELING OF BODY TEMPERATURE CHANGE (feels hot and cold), TREMOR (shakes like she was nervous), DYSPHONIA (hoarse) and NAUSEA (nauseated) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Shellfish allergy, Seafood allergy, Penicillin allergy, Iodine allergy, Drug allergy (Phenergan.) and Blood pressure high. Concomitant products included AMLODIPINE, FLUOXETINE and GABAPENTIN for an unknown indication. On 22-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, the patient experienced HYPERHIDROSIS (sweating bad), FEELING OF BODY TEMPERATURE CHANGE (feels hot and cold), TREMOR (shakes like she was nervous), DYSPHONIA (hoarse), NAUSEA (nauseated), VOMITING (throwing up) and HEADACHE (headache). The patient was treated with ONDANSETRON (ZOFRAN [ONDANSETRON]) for Nausea, at an unspecified dose and frequency. At the time of the report, HYPERHIDROSIS (sweating bad), FEELING OF BODY TEMPERATURE CHANGE (feels hot and cold), TREMOR (shakes like she was nervous), DYSPHONIA (hoarse), NAUSEA (nauseated), VOMITING (throwing up) and HEADACHE (headache) outcome was unknown.

Other Meds: AMLODIPINE; FLUOXETINE; GABAPENTIN

Current Illness: Blood pressure high; Drug allergy (Phenergan.); Iodine allergy; Penicillin allergy; Seafood allergy; Shellfish allergy

ID: 1562534
Sex: F
Age: 69
State: NC

Vax Date: 03/03/2021
Onset Date: 03/04/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: fatigue; muscle pain; headache; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue), MYALGIA (muscle pain) and HEADACHE (headache) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination. Concomitant products included METFORMIN and AMLODIPINE for an unknown indication. On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced FATIGUE (fatigue), MYALGIA (muscle pain) and HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 05-Mar-2021, MYALGIA (muscle pain) had resolved. At the time of the report, FATIGUE (fatigue) and HEADACHE (headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. concomitant medications include airborne vitamins. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.

Other Meds: METFORMIN; AMLODIPINE

Current Illness:

ID: 1562535
Sex: M
Age: 57
State: VA

Vax Date: 02/24/2021
Onset Date: 02/24/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: irritation rather than a real cough; dry cough, cough is lingering; feels like I am at the end of a cold; little bit queasy; fatigued; muscle pain, felt like someone punch me in the arm twice; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of THROAT IRRITATION (irritation rather than a real cough), COUGH (dry cough, cough is lingering), MALAISE (feels like I am at the end of a cold), MYALGIA (muscle pain, felt like someone punch me in the arm twice) and NAUSEA (little bit queasy) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Asthma. On 24-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced MYALGIA (muscle pain, felt like someone punch me in the arm twice). On 25-Feb-2021, the patient experienced NAUSEA (little bit queasy) and FATIGUE (fatigued). On 26-Feb-2021, the patient experienced THROAT IRRITATION (irritation rather than a real cough), COUGH (dry cough, cough is lingering) and MALAISE (feels like I am at the end of a cold). On 26-Feb-2021, NAUSEA (little bit queasy) and FATIGUE (fatigued) had resolved. On 27-Feb-2021, MYALGIA (muscle pain, felt like someone punch me in the arm twice) had resolved. At the time of the report, THROAT IRRITATION (irritation rather than a real cough), COUGH (dry cough, cough is lingering) and MALAISE (feels like I am at the end of a cold) had not resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant product use was not provided by the reporter. No treatment information was provided. This case was linked to MOD-2021-034373 (Patient Link).

Other Meds:

Current Illness:

ID: 1562536
Sex: F
Age: 59
State: NY

Vax Date: 02/28/2021
Onset Date: 02/28/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Rash on Palm; Headache; Fever; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash on Palm), HEADACHE (Headache) and PYREXIA (Fever) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination. No Medical History information was reported. On 28-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 2 dosage form. On 28-Feb-2021, the patient experienced RASH (Rash on Palm), HEADACHE (Headache) and PYREXIA (Fever). At the time of the report, RASH (Rash on Palm), HEADACHE (Headache) and PYREXIA (Fever) outcome was unknown. No concomitant medications were reported. No treatment related information has been reported

Other Meds:

Current Illness:

ID: 1562537
Sex: F
Age: 74
State: NY

Vax Date: 03/01/2021
Onset Date: 03/02/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination. Concomitant products included PREDNISONE. On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No treatment information was provided. This case was linked to MOD-2021-031654 (Patient Link).

Other Meds: PREDNISONE

Current Illness:

ID: 1562538
Sex: F
Age: 64
State: PA

Vax Date: 02/02/2021
Onset Date: 03/02/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fever; fatigue; Headache; Chills; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), FATIGUE (fatigue), HEADACHE (Headache), CHILLS (Chills) and MYALGIA (Body aches) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014M10A and 030L20A) for COVID-19 vaccination. No Medical History was provided by the reporter. Concomitant products included VITAMIN and LISINOPRIL for an unknown indication. On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Mar-2021, the patient experienced PYREXIA (Fever), FATIGUE (fatigue), HEADACHE (Headache), CHILLS (Chills) and MYALGIA (Body aches). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, PYREXIA (Fever), FATIGUE (fatigue), HEADACHE (Headache), CHILLS (Chills) and MYALGIA (Body aches) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Mar-2021, Body temperature: 101 f (High) Patient had fever of 101 F. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.

Other Meds: VITAMIN; LISINOPRIL

Current Illness:

ID: 1562539
Sex: F
Age: 71
State: OH

Vax Date: 02/23/2021
Onset Date: 02/23/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: itchiness below the injection site/spreading; redness below the injection site; muscle pain on my neck; This spontaneous case was reported by a health care professional and describes the occurrence of NECK PAIN (muscle pain on my neck), VACCINATION SITE PRURITUS (itchiness below the injection site/spreading) and VACCINATION SITE ERYTHEMA (redness below the injection site) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. Concurrent medical conditions included Shellfish allergy. Concomitant products included CALCIUM, FISH OIL and ASCORBIC ACID, BIOFLAVONOIDS NOS, HESPERIDIN, MALPIGHIA GLABRA, ROSA CANINA, RUTOSIDE (VITAMIN C [ASCORBIC ACID;BIOFLAVONOIDS NOS;HESPERIDIN;MALPIGHIA GLABRA;ROSA CANINA;RUTOSIDE]) for an unknown indication. On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced NECK PAIN (muscle pain on my neck). On 03-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (itchiness below the injection site/spreading) and VACCINATION SITE ERYTHEMA (redness below the injection site). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. At the time of the report, NECK PAIN (muscle pain on my neck), VACCINATION SITE PRURITUS (itchiness below the injection site/spreading) and VACCINATION SITE ERYTHEMA (redness below the injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: NNI updated for 1st dose of Vaccine

Other Meds: CALCIUM; FISH OIL; VITAMIN C [ASCORBIC ACID;BIOFLAVONOIDS NOS;HESPERIDIN;MALPIGHIA GLABRA;ROSA CANINA;RUTOSIDE]

Current Illness: Shellfish allergy

ID: 1562540
Sex: F
Age:
State: CA

Vax Date: 01/31/2021
Onset Date: 01/31/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: 36 days since the first dose; Flu-like symptoms; Fever; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (36 days since the first dose), INFLUENZA LIKE ILLNESS (Flu-like symptoms), PYREXIA (Fever) and MYALGIA (Body aches) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination. Concurrent medical conditions included Thyroid disorder NOS. Concomitant products included THYROID for Thyroid disorder NOS, CLOPIDOGREL BISULFATE (PLAVIX) and ATENOLOL for an unknown indication. On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Jan-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu-like symptoms), PYREXIA (Fever) and MYALGIA (Body aches). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (36 days since the first dose). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PRODUCT DOSE OMISSION ISSUE (36 days since the first dose) outcome was unknown and INFLUENZA LIKE ILLNESS (Flu-like symptoms), PYREXIA (Fever) and MYALGIA (Body aches) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 31-Jan-2021, Body temperature: 100.0 (High) Fahrenheit. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.

Other Meds: PLAVIX; ATENOLOL; THYROID

Current Illness: Thyroid disorder NOS

ID: 1562541
Sex: F
Age: 72
State: NC

Vax Date: 02/11/2021
Onset Date: 02/11/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fluctuating INR; This spontaneous case was reported by a consumer and describes the occurrence of INTERNATIONAL NORMALISED RATIO FLUCTUATION (Fluctuating INR) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concomitant products included DULAGLUTIDE (TRULICITY), INSULIN, METFORMIN, GLIPIZIDE, METOPROLOL, WARFARIN, WARFARIN and LOSARTAN. On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced INTERNATIONAL NORMALISED RATIO FLUCTUATION (Fluctuating INR). At the time of the report, INTERNATIONAL NORMALISED RATIO FLUCTUATION (Fluctuating INR) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Treatment information was not provided.

Other Meds: TRULICITY; INSULIN; METFORMIN; GLIPIZIDE; METOPROLOL; WARFARIN; WARFARIN; LOSARTAN

Current Illness:

ID: 1562542
Sex: F
Age: 72
State: NH

Vax Date: 03/03/2021
Onset Date: 03/04/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: did not feel well; dry heaves; bedridden; fever; headache; chills; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (did not feel well), RETCHING (dry heaves), BEDRIDDEN (bedridden), PYREXIA (fever) and HEADACHE (headache) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced MALAISE (did not feel well), RETCHING (dry heaves), BEDRIDDEN (bedridden), PYREXIA (fever), HEADACHE (headache) and CHILLS (chills). At the time of the report, MALAISE (did not feel well), RETCHING (dry heaves), BEDRIDDEN (bedridden), PYREXIA (fever), HEADACHE (headache) and CHILLS (chills) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided by the reporter. No treatment information was provided. This case was linked to MOD-2021-034401 (Patient Link).

Other Meds:

Current Illness:

ID: 1562543
Sex: F
Age: 66
State: AR

Vax Date: 02/27/2021
Onset Date: 02/27/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (arm is so huge and so swollen), HEART RATE INCREASED (heart started acting up/beating erratic like) and HEART RATE IRREGULAR (beating erratic-like) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. Concurrent medical conditions included Food allergy (Patient is allergic to dairy products) and Allergy to chemicals (Patient is allergic to Bactrim). Concomitant products included ZINC for an unknown indication. On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced VACCINATION SITE SWELLING (arm is so huge and so swollen), HEART RATE INCREASED (heart started acting up/beating erratic like) and HEART RATE IRREGULAR (beating erratic-like). On 01-Mar-2021, HEART RATE INCREASED (heart started acting up/beating erratic like) and HEART RATE IRREGULAR (beating erratic-like) had resolved. At the time of the report, VACCINATION SITE SWELLING (arm is so huge and so swollen) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Patient's treatment medication included Heart pill taken half a pill to make sure that heart beats right and hot compress on the injection site. Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: Patient sick, declined further FU

Other Meds: ZINC

Current Illness: Allergy to chemicals (Patient is allergic to Bactrim); Food allergy (Patient is allergic to dairy products)

ID: 1562544
Sex: F
Age:
State:

Vax Date: 01/21/2021
Onset Date: 03/01/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Blisters in mouth and throat; swelling on face; This spontaneous case was reported by a consumer and describes the occurrence of BLISTER (Blisters in mouth and throat) and SWELLING FACE (swelling on face) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History was provided by the reporter. Concurrent medical conditions included Penicillin allergy. On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Mar-2021, the patient experienced BLISTER (Blisters in mouth and throat) and SWELLING FACE (swelling on face). At the time of the report, BLISTER (Blisters in mouth and throat) and SWELLING FACE (swelling on face) outcome was unknown. Patient stated that she takes many medications but could not provide details of them. No treatment information was provided.

Other Meds:

Current Illness: Penicillin allergy.

ID: 1562545
Sex: M
Age: 95
State: FL

Vax Date: 03/02/2021
Onset Date: 03/02/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: A little tenderness at the arm of the injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (A little tenderness at the arm of the injection) in a 95-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. No Medical History information was reported. On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced VACCINATION SITE PAIN (A little tenderness at the arm of the injection). At the time of the report, VACCINATION SITE PAIN (A little tenderness at the arm of the injection) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications provided by the reporter included blood pressure medication, heart medication, diabetes medication and some other medications which the reporter was not able to remember. No treatment information was provided. Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: The event outcome was updated to recovered.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 679,999

Page last modified: 03 October 2021 5:28pm